UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium

Pathogens and disease, 2013-11, Vol.69 (2), p.87-100

2013

Link zum Volltext

Verfügbarkeit prüfen

Peptidomimetic furin inhibitor MI-701 in combination with oseltamivir and ribavirin efficiently blocks propagation of highly pathogenic avian influenza viruses and delays high level oseltamivir resistance in MDCK cells

Antiviral research, 2015-08, Vol.120, p.89-100

2015

Link zum Volltext

Verfügbarkeit prüfen

The role of glycosylation in the N-terminus of the hemagglutinin of a unique H4N2 with a natural polybasic cleavage site in virus fitness in vitro and in vivo

Virulence, 2021-12, Vol.12 (1), p.666-678

2021

Link zum Volltext

Verfügbarkeit prüfen

Structures and distributions of SARS-CoV-2 spike proteins on intact virions

Nature (London), 2020-12, Vol.588 (7838), p.498-502

2020

Link zum Volltext

Verfügbarkeit prüfen

Global patterns of avian influenza A (H7): virus evolution and zoonotic threats

FEMS microbiology reviews, 2019-11, Vol.43 (6), p.608-621

2019

Link zum Volltext

Verfügbarkeit prüfen

Fusion of Enveloped Viruses in Endosomes

Traffic (Copenhagen, Denmark), 2016-06, Vol.17 (6), p.593-614

2016

Link zum Volltext

Verfügbarkeit prüfen

SPINK6 inhibits human airway serine proteases and restricts influenza virus activation

EMBO molecular medicine, 2022-01, Vol.14 (1), p.e14485-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of inhaled pollutants on response to viral infection in controlled exposures

Journal of allergy and clinical immunology, 2021-12, Vol.148 (6), p.1420-1429

2021

Link zum Volltext

Verfügbarkeit prüfen

Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

Pharmacology & therapeutics (Oxford), 2020-09, Vol.213, p.107587-107587, Article 107587

2020

Link zum Volltext

Verfügbarkeit prüfen

Exacerbation of disease by intranasal liquid administration following influenza virus infection in mice

Pathogens and disease, 2020-03, Vol.78 (2)

2020

Link zum Volltext

Verfügbarkeit prüfen

Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)

International journal of cancer, 2012-03, Vol.130 (6), p.1338-1346

2012

Link zum Volltext

Verfügbarkeit prüfen

Type II transmembrane serine proteases as potential targets for cancer therapy

Biological chemistry, 2016-09, Vol.397 (9), p.815

2016

Link zum Volltext

Verfügbarkeit prüfen

Biomedical nanoparticle design: What we can learn from viruses

Journal of controlled release, 2021-01, Vol.329, p.552-569

2021

Link zum Volltext

Verfügbarkeit prüfen

Current status on the development of pseudoviruses for enveloped viruses

Reviews in medical virology, 2018-01, Vol.28 (1), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Peptide-Based Vaccines and Therapeutics for COVID-19

International journal of peptide research and therapeutics, 2022-05, Vol.28 (3), p.94-94, Article 94

2022

Link zum Volltext

Verfügbarkeit prüfen

Influenza virus‐mediated suppression of bronchial Chitinase‐3‐like 1 secretion promotes secondary pneumococcal infection

The FASEB journal, 2020-12, Vol.34 (12), p.16432-16448

2020

Link zum Volltext

Verfügbarkeit prüfen

Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy

Pharmacological research, 2022-08, Vol.182, p.106334-106334, Article 106334

2022

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action

Life sciences (1973), 2020-12, Vol.262, p.118493-11, Article 118493

2020

Link zum Volltext

Verfügbarkeit prüfen

Stem cells or their exosomes: which is preferred in COVID-19 treatment?

Biotechnology letters, 2022-02, Vol.44 (2), p.159-177

2022

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal stem cells attenuate the proinflammatory cytokine pattern in a guinea pig model of chronic cigarette smoke exposure

Cytokine (Philadelphia, Pa.), 2023-02, Vol.162, p.156104-156104, Article 156104

2023

Link zum Volltext

Verfügbarkeit prüfen

Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS‐CoV‐2 drug targets: in vitro validation of furin inhibition

Phytotherapy research, 2021-02, Vol.35 (2), p.908-919

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunology of SARS-CoV-2 Infection

Biochemistry (Moscow), 2024, Vol.89 (1), p.65-83

2024

Link zum Volltext

Verfügbarkeit prüfen

Translating bioactive peptides for COVID-19 therapy

European journal of pharmacology, 2021-01, Vol.890, p.173661-173661, Article 173661

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium

Peptidomimetic furin inhibitor MI-701 in combination with oseltamivir and ribavirin efficiently blocks propagation of highly pathogenic avian influenza viruses and delays high level oseltamivir resistance in MDCK cells

The role of glycosylation in the N-terminus of the hemagglutinin of a unique H4N2 with a natural polybasic cleavage site in virus fitness in vitro and in vivo

Structures and distributions of SARS-CoV-2 spike proteins on intact virions

Microphthalmia, parkinsonism, and enhanced nociception in Pitx3 ⁴¹⁶insG mice

Microphthalmia, parkinsonism, and enhanced nociception in Pitx3416insG mice

Global patterns of avian influenza A (H7): virus evolution and zoonotic threats

Fusion of Enveloped Viruses in Endosomes

SPINK6 inhibits human airway serine proteases and restricts influenza virus activation

Impact of inhaled pollutants on response to viral infection in controlled exposures

Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

Exacerbation of disease by intranasal liquid administration following influenza virus infection in mice

Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)

Type II transmembrane serine proteases as potential targets for cancer therapy

Biomedical nanoparticle design: What we can learn from viruses

Current status on the development of pseudoviruses for enveloped viruses

Peptide-Based Vaccines and Therapeutics for COVID-19

Influenza virus‐mediated suppression of bronchial Chitinase‐3‐like 1 secretion promotes secondary pneumococcal infection

Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy

Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action

Stem cells or their exosomes: which is preferred in COVID-19 treatment?

Mesenchymal stem cells attenuate the proinflammatory cytokine pattern in a guinea pig model of chronic cigarette smoke exposure

Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS‐CoV‐2 drug targets: in vitro validation of furin inhibition

Immunology of SARS-CoV-2 Infection

Translating bioactive peptides for COVID-19 therapy

Aktive Filter

Suchergebnisse filtern